Clinical Trials Logo

Bladder Outlet Obstruction clinical trials

View clinical trials related to Bladder Outlet Obstruction.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05470751 Completed - Multiple Sclerosis Clinical Trials

GentleCath™ for Men Intermittent Catheter With FeelClean™ Technology

Start date: February 2, 2023
Phase:
Study type: Observational

Male self catherterisng observational study.

NCT ID: NCT04981080 Completed - Clinical trials for Bladder Outlet Obstruction

DU and BOO in Women With and Without Symptoms of VD

Start date: February 1, 2005
Phase:
Study type: Observational

Women with symptoms of voiding dysfunction may be associated with detrusor underactivity or bladder outlet obstruction. However, the prevalence of detrusor underactivity and bladder outlet obstruction remained obscure. Thus, the aim of this study was to elucidate the prevalence of detrusor underactivity and bladder outlet obstruction in women with and without symptoms of voiding dysfunction.

NCT ID: NCT02031653 Completed - Clinical trials for Bladder Outlet Obstruction

Comparison Between Invasive Pressure Flow Study and Non-invasive Penile Cuff Test

Start date: January 2014
Phase:
Study type: Observational

To provide evidence of promising tests to noninvasively diagnose bladder outlet obstruction (BOO) in men with benign prostatic hyperplasia. 1. Penile cuff test provides a means of obtaining a urodynamic diagnosis with a high level of accuracy without the morbidity and expense of invasive Pressure flow study. 2. Penile cuff test may be particularly useful in the counseling of patients prior to benign prostatic hyperplasia operation. Patients diagnosed as obstructed following a penile cuff test can be reassured that surgery has a high chance of resulting in symptomatic benefit

NCT ID: NCT01661621 Completed - Clinical trials for Bladder Outlet Obstruction

Antimuscarinics as the First-line Treatment for Male With IPSS-V/S≤1

Start date: August 2012
Phase: Phase 4
Study type: Interventional

This study is a prospective randomized, open label, controlled, double arm, post-marketing study to compare the treatment efficacy of first-line antimuscarinics and α-blockers monotherapy for men with moderate to severe lower urinary tract symptoms (LUTS) (International Prostate Symptom Score (IPSS-T) ≥8) and IPSS voiding-to-storage subscore ratio (IPSS-V/S) ≤1.

NCT ID: NCT00710749 Completed - Clinical trials for Lower Urinary Tract Symptoms

The Value of Multiple Urine Flow Rate Measurements in Male Benign Prostatic Hyperplasia (BPH) Subjects

Start date: July 2008
Phase: N/A
Study type: Interventional

Crossover comparison of different flow meters with a digital home flow meter as a reference. Main hypothesis: Reapeated home flow measurements with a disposable device will provide a better understanding of the patients urinary flow than a single measurement performed in the clinic.

NCT ID: NCT00605319 Completed - Clinical trials for Bladder Outlet Obstruction

An Open Label Study to Measure Efficacy of Fesoterodine (Toviaz) Post Surgery for Benign Prostatic Hyperplasia

Toviaz
Start date: January 2010
Phase: Phase 4
Study type: Interventional

The subjects who have symptoms of overactive bladder (many trips to the bathroom, and urgency with or without the inability to hold your urine until you get to the toilet) are invited to participate in this research study.

NCT ID: NCT00507455 Completed - Clinical trials for Lower Urinary Tract Symptoms

Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction

Start date: June 2007
Phase: Phase 2
Study type: Interventional

A study to evaluate the safety of the co-administration of solifenacin succinate with tamsulosin hydrochloride in men with lower urinary tract symptoms (LUTS) and bladder outlet obstruction (BOO).

NCT ID: NCT00410514 Completed - Clinical trials for Lower Urinary Tract Symptoms

A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO)

Start date: December 2006
Phase: Phase 2
Study type: Interventional

This study examined the safety, tolerability, and efficacy of mirabegron (YM178) compared to placebo.